GoodRx Inc.
Rating
Updated: Sep 5, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform...
Latest News
18 days ago · pymnts.com
GoodRx Covers Whole Households and Pets in New Prescription PlanPrescription platform GoodRx has launched a new plan that covers a primary member and up to four dependents, including children, adult family members and pets, the company said in a Thursday (Sept. 3) press release.
1 month ago · seekingalpha.com
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering HopeGoodRx has rebounded from $2.50 per share, showing renewed growth momentum and improved consumer traction. New offerings have contributed to GDRX's recent positive developments, but the stock's rapid appreciation reflects these improvements. I remain marginally more positive, yet GDRX still presents considerable risk, warranting a continued neutral rating.
2 months ago · seekingalpha.com
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call TranscriptGoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
2 months ago · marketbeat.com
GoodRx Q2 Earnings Call HighlightsGoodRx NASDAQ: GDRX reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and subscription businesses offset pressure in prescription transaction revenue.
2 months ago · pymnts.com
GoodRx and Oscar Health Tout Tech as Consumer Needs ChangeThe latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.
2 months ago · zacks.com
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match EstimatesGoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
2 months ago · zacks.com
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesThe headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
3 months ago · businesswire.com
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference CallSANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's bus.
3 months ago · zacks.com
GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?GoodRx (GDRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
3 months ago · zacks.com
GDRX or HQY: Which Is the Better Value Stock Right Now?Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Analyst Summary
Add to Watchlist
Select watchlists to add or remove GDRX